Categories : Oncology
Product Packaging : 30 in HDPE
Product Composition : 200mg
Sorafenib tablets are targeted oncology medicines classified as multikinase inhibitors, primarily used in the treatment of hepatocellular carcinoma (liver cancer), renal cell carcinoma, and differentiated thyroid cancer. The formulation works by inhibiting multiple intracellular and cell surface kinases involved in tumor growth and angiogenesis, helping to slow cancer progression.
In international pharmaceutical markets, Sorafenib tablets exporter India and liver cancer medicine supplier India are widely searched by oncology distributors and specialty drug importers. Genliva Wellness LLP, Himatnagar, operates as a pharma exporter India multikinase inhibitor medicines partner, supplying high-demand targeted therapies to global healthcare providers and pharmaceutical companies.
Send MessageSorafenib tablets are targeted oncology medicines classified as multikinase inhibitors, primarily used in the treatment of hepatocellular carcinoma (liver cancer), renal cell carcinoma, and differentiated thyroid cancer. The formulation works by inhibiting multiple intracellular and cell surface kinases involved in tumor growth and angiogenesis, helping to slow cancer progression.
In international pharmaceutical markets, Sorafenib tablets exporter India and liver cancer medicine supplier India are widely searched by oncology distributors and specialty drug importers. Genliva Wellness LLP, Himatnagar, operates as a pharma exporter India multikinase inhibitor medicines partner, supplying high-demand targeted therapies to global healthcare providers and pharmaceutical companies.
